Cargando…

T44. A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF THE EFFECTS OF VITAMIN B12, B6 AND FOLIC ACID ON COGNITION AND SYMPTOMS IN FIRST-EPISODE PSYCHOSIS: THE VITAMINS IN PSYCHOSIS STUDY

BACKGROUND: Vitamin B12, vitamin B6 and folic acid are homocysteine-reducing agents. People with schizophrenia have been found to have increased homocysteine levels. Elevated homocysteine has been associated with impaired cognition. Previous research in chronic schizophrenia has shown that supplemen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Allott, Kelly, McGorry, Patrick, Yuen, Hok Pan, O’Donnell, Colin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887527/ http://dx.doi.org/10.1093/schbul/sby016.320

Ejemplares similares

Differentiating the effect of antipsychotic medication and illness on brain volume reductions in first-episode psychosis: A Longitudinal, Randomised, Triple-blind, Placebo-controlled MRI Study
por: Chopra, Sidhant, et al.
Publicado: (2021)

Cognitive ability and metabolic physical health in first-episode psychosis
por: Whitson, Sarah, et al.
Publicado: (2021)

S166. EFFECTIVE CONNECTIVITY OF FRONTOSTRIATAL SYSTEMS IN FIRST-EPISODE PSYCHOSIS
por: Sabaroedin, Kristina, et al.
Publicado: (2020)

Discharge destinations for young people with a first episode of psychosis after attending an early intervention for psychosis service
por: O’Donoghue, Brian, et al.
Publicado: (2023)

Gradients of striatal function in antipsychotic-free first-episode psychosis and schizotypy
por: Oldehinkel, Marianne, et al.
Publicado: (2023)

T119. CAN SOME YOUNG PEOPLE RECOVER FROM FIRST-EPISODE PSYCHOSIS WITH INTEGRATED PSYCHOSOCIAL TREATMENT WITHOUT ANTIPSYCHOTIC MEDICATIONS? AN RCT TO ASSESS RISKS, BENEFITS, AND RANGE OF OUTCOMES
por: McGorry, Patrick, et al.
Publicado: (2018)

ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis
por: Cotton, S. M., et al.
Publicado: (2019)

Vascular Endothelial Growth Factor and Brain-Derived Neurotrophic Factor in Quetiapine Treated First-Episode Psychosis
por: Murphy, Brendan P., et al.
Publicado: (2014)

The Positive and Negative Experiences of Caregiving for Siblings of Young People with First Episode Psychosis
por: Bowman, Siann, et al.
Publicado: (2017)

A single-blind, randomised controlled trial of a physical health nurse intervention to prevent weight gain and metabolic complications in first-episode psychosis: the Physical Health Assistance in Early Psychosis (PHAstER) study
por: O'Donoghue, Brian, et al.
Publicado: (2022)

Early Intervention in Psychosis: Obvious, Effective, Overdue
por: McGorry, Patrick D.
Publicado: (2015)

Symptomatic Correlates of Vitamin D Deficiency in First-Episode Psychosis
por: Coentre, Ricardo, et al.
Publicado: (2019)

S130. INCIDENCE OF FIRST EPISODE OF PSYCHOSIS IN AN AUSTRALIAN COHORT AND ASSOCIATIONS WITH NEIGHBOURHOOD CHARACTERISTICS
por: Eaton, Scott, et al.
Publicado: (2018)

Very Low-Dose Risperidone in First-Episode Psychosis: A Safe and Effective Way to Initiate Treatment
por: McGorry, Patrick D., et al.
Publicado: (2011)

Vitamin D supplementation compared to placebo in people with First Episode psychosis - Neuroprotection Design (DFEND): a protocol for a randomised, double-blind, placebo-controlled, parallel-group trial
por: Gaughran, Fiona, et al.
Publicado: (2020)

Randomized Controlled Trial of Clozapine and CBT for First-Episode Psychosis with Enduring Positive Symptoms: A Pilot Study
por: Edwards, J., et al.
Publicado: (2011)

Functional Connectivity in Antipsychotic-Treated and Antipsychotic-Naive Patients With First-Episode Psychosis and Low Risk of Self-harm or Aggression: A Secondary Analysis of a Randomized Clinical Trial
por: Chopra, Sidhant, et al.
Publicado: (2021)

Frontostriatothalamic effective connectivity and dopaminergic function in the psychosis continuum
por: Sabaroedin, Kristina, et al.
Publicado: (2022)

Divergent effects of first-generation and second-generation antipsychotics on cortical thickness in first-episode psychosis
por: Ansell, B. R. E., et al.
Publicado: (2015)

19.4 CAT IN FIRST-EPISODE PSYCHOSIS: FEASIBILITY, ACCEPTABILITY AND POTENTIAL TO ENHANCE VOCATIONAL RECOVERY
por: Allott, Kelly
Publicado: (2018)

S8. RELATIONSHIP BETWEEN ALLOSTATIC LOAD AND POOR FUNCTIONAL CAPACITY IN YOUTH AT ULTRA-HIGH RISK FOR PSYCHOSIS
por: Berger, Maximus, et al.
Publicado: (2018)

T121. RATES AND PREDICTORS OF RELAPSE FOLLOWING DISCONTINUATION OF ANTIPSYCHOTIC MEDICATION AFTER A FIRST EPISODE OF PSYCHOSIS
por: Bowtell, Meghan, et al.
Publicado: (2018)

Psychosis as a symptom of Vitamin B12 deficiency. Report of one case
por: Calle-Gonzalez, A., et al.
Publicado: (2021)

T30. TIPPING POINTS – PREDICTING TRANSITIONS TO PSYCHOSIS IN AT-RISK YOUNG PEOPLE
por: Hartmann, Jessica A, et al.
Publicado: (2018)

Social Functioning Trajectories of Young First-Episode Psychosis Patients with and without Cannabis Misuse: A 30-Month Follow-Up Study
por: González-Blanch, César, et al.
Publicado: (2015)

Persistent negative symptoms in individuals at Ultra High Risk for psychosis
por: Yung, Alison R., et al.
Publicado: (2019)

Heterogeneity of quality of life in the later stages of first-episode psychosis recovery
por: Clarke, E. L., et al.
Publicado: (2022)

The need for early intervention for psychosis to persist throughout the COVID-19 pandemic and beyond
por: O’Donoghue, B., et al.
Publicado: (2020)

Cognitive strengths in first episode psychosis: a thematic analysis of clinicians’ perspectives
por: Steele, Peter, et al.
Publicado: (2021)

Psychosis and Seizures Attributed to Severe Vitamin B12 Deficiency: A Case Report
por: Portillo, Shellsea, et al.
Publicado: (2023)

Key Worker–Mediated Enhancement of Physical Health in First Episode Psychosis: Protocol For a Feasibility Study in Primary Care
por: McCombe, Geoff, et al.
Publicado: (2019)

4.3 ENHANCING SOCIAL FUNCTIONING AND LONG-TERM RECOVERY IN YOUNG PEOPLE WITH FIRST EPISODE PSYCHOSIS (FEP) AND YOUNG PEOPLE AT ULTRA HIGH RISK (UHR) FOR PSYCHOSIS: A NOVEL ONLINE SOCIAL THERAPY APPROACH
por: Alvarez-Jimenez, Mario, et al.
Publicado: (2018)

Correlation between BDNF levels and folic acid levels at baseline in drug-naïve First Episode Psychosis
por: Toll, A., et al.
Publicado: (2023)

Vitamin B(12) and Folic Acid in the Megaloblastic Anæmias
por: Girdwood, Ronald H.
Publicado: (1951)

Commentary: Preventive Treatments for Psychosis: Umbrella Review (Just the Evidence)
por: Nelson, Barnaby, et al.
Publicado: (2020)

Recent Meta-Analyses in the Clinical High Risk for Psychosis Population: Clinical Interpretation of Findings and Suggestions for Future Research
por: Nelson, Barnaby, et al.
Publicado: (2018)

Clinical correlates of vitamin D deficiency in established psychosis
por: Lally, J., et al.
Publicado: (2016)

M21. THE STEP TRIAL: A SEQUENTIAL MULTIPLE ASSIGNMENT RANDOMISED TRIAL (SMART) OF INTERVENTIONS FOR PATIENTS AT ULTRA-HIGH RISK OF PSYCHOSIS - STUDY RATIONALE, DESIGN AND BASELINE DATA
por: Nelson, Barnaby, et al.
Publicado: (2020)

Folic Acid and Vitamin B12 Administration in CKD, Why Not?
por: Capelli, Irene, et al.
Publicado: (2019)

Erythrocyte glutathione levels as long-term predictor of transition to psychosis
por: Lavoie, S, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kvo6aiuae8t9ik93kgba9333p1